SPPAM
LLY icon

Summit Partners Public Asset Management’s Eli Lilly LLY Stock Holding History

Summit Partners Public Asset Management’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-40,000
Closed -$31.1M – 133
2024
Q1 		$31.1M Buy
+40,000
New +$28.5M 1.07% 39
2017
Q4 		– Sell
-50,000
Closed -$4.28M – 106
2017
Q3 		$4.28M Buy
+50,000
New +$4.1M 0.58% 65

Other funds holding LLY

PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Summit Partners Public Asset Management's LLY Position: Q1 2025 in Review

Summit Partners Public Asset Management sold out of Eli Lilly (LLY) in Q1 2025, closing a stake of 31,592 shares — an estimated $24.4M sold.

Summit Partners Public Asset Management first reported a position in LLY in Q2 2023 and held it in 7 quarters. The position peaked at $64.2M in Q3 2024. 3,920 funds tracked by Wall St. Rank hold LLY as of Q1 2025.

  • Summit Partners Public Asset Management reported no remaining Eli Lilly position as of Q1 2025 after selling out during the quarter.
  • Summit Partners Public Asset Management sold 31,592 Eli Lilly shares in Q1 2025, an estimated $24.4M.
  • Summit Partners Public Asset Management first reported a position in Eli Lilly in Q2 2023 and held it in 7 quarters.
  • Summit Partners Public Asset Management's Eli Lilly position peaked at $64.2M in Q3 2024.
  • 3,920 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2025.

Based on Summit Partners Public Asset Management's 13F filing for Q1 2025, filed 15 May 2025.